cephalexin has been researched along with Primary Peritonitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dombros, N; Finer, C; Low, DE; Manuel, MA; Oreopoulos, DG; Saiphoo, MM; Vas, SI | 1 |
| Casewell, MW; Desai, N; Drew, PJ; Houang, ET; Marsh, FP; Simpson, CN | 1 |
| Aronoff, GR; Brier, ME; Bunke, CM; Luft, FC; Sloan, RS | 1 |
| Elo, J; Gripenberg, L; Nuutinen, P; Tallgren, LG | 1 |
| Gahrn-Hansen, B; Hornstrup, MK; Klausen, M; Nielsen, TG; Pedersen, FB | 1 |
| Tauchnitz, C | 1 |
| Messana, J; Reynolds, J; Starmann, B; Swartz, R; Weber, M | 1 |
| Cutler, RE; Davis, GM; Forland, SC | 1 |
3 trial(s) available for cephalexin and Primary Peritonitis
| Article | Year |
|---|---|
Prophylactic cephalexin ineffective in chronic ambulatory peritoneal dialysis.
Topics: Bacteria; Bacterial Infections; Catheterization; Cephalexin; Humans; Peritoneal Dialysis; Peritonitis; Staphylococcus | 1980 |
Tobramycin-clindamycin versus cephalothin-cephalexin in the treatment of appendicular peritonitis.
Topics: Adolescent; Aerobiosis; Anaerobiosis; Appendicitis; Ascitic Fluid; Bacteria; Cephalexin; Cephalothin; Child; Child, Preschool; Clindamycin; Drug Therapy, Combination; Female; Humans; Infant; Intestinal Perforation; Male; Peritonitis; Tobramycin | 1981 |
Preventing Staphylococcus aureus infection during chronic peritoneal dialysis.
Topics: Actuarial Analysis; Adult; Carrier State; Catheters, Indwelling; Cephalexin; Child; Clindamycin; Foreign-Body Reaction; Humans; Nasal Cavity; Peritoneal Dialysis; Peritonitis; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Umbilicus | 1991 |
5 other study(ies) available for cephalexin and Primary Peritonitis
| Article | Year |
|---|---|
Cephalexin for the oral treatment of CAPD peritonitis.
Topics: Administration, Oral; Cephalexin; Escherichia coli Infections; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Streptococcal Infections | 1984 |
Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Biological Availability; Cefazolin; Cephalexin; Female; Half-Life; Humans; Injections, Intraperitoneal; Kinetics; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1983 |
[Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Evaluation of cephalothin/cephalexin monotherapy as initial treatment].
Topics: Adolescent; Adult; Aged; Cephalexin; Cephalothin; Child; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Retrospective Studies | 1993 |
[The cephalosporins and their clinical value].
Topics: Abortion, Septic; Animals; Cefazolin; Cephacetrile; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cephradine; Female; Humans; Mice; Penicillin Resistance; Penicillinase; Penicillins; Peritonitis; Pneumonia; Pregnancy; Staphylococcal Infections; Streptococcus; Urinary Tract Infections | 1976 |
Serum and dialysate concentrations of cephalexin following repeated dosing in CAPD patients.
Topics: Administration, Oral; Adult; Bacterial Infections; Cephalexin; Feasibility Studies; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Time Factors | 1985 |